Peroxiredoxins in breast carcinoma

Clinical Cancer Research

Volumn 9, Issue 9, 2003, Pages 3418-3424

  Karihtala, Peeter ^a   Mäntyniemi, Anne ^a   Kang, Sang Won ^b   Kinnula, Vuokko L ^a,c   Soini, Ylermi ^a  

^a UNIVERSITY OF OULU   (Finland)

^b Ewha Womans University   (South Korea)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; HORMONE RECEPTOR; PEROXIREDOXIN; PEROXIREDOXIN I; PEROXIREDOXIN III; PEROXIREDOXIN IV; PEROXIREDOXIN V; PROGESTERONE RECEPTOR; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; CANCER CLASSIFICATION; CANCER SURVIVAL; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SURVIVAL RATE; TUMOR VOLUME;

ANTIOXIDANTS; APOPTOSIS; BREAST NEOPLASMS; CARCINOMA; CELL DIFFERENTIATION; CELL DIVISION; CELL SURVIVAL; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM METASTASIS; PEROXIDASES; PROTEIN ISOFORMS; REACTIVE OXYGEN SPECIES; RECEPTORS, PROGESTERONE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0041333104     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Wright, R. M., McManaman, J. L., and Repine, J. E. Alcohol-induced breast cancer: a proposed mechanism. Free Rad. Biol. Med., 26 (3-4): 348-354, 1999.
2. Jomot, L., Petersen, H., and Junod, A. F. Hydrogen peroxide-induced DNA damage is independent of nuclear calcium but dependent on redox-active ions. Biochem. J., 335: 85-94, 1998.
3. Klaunig, J. E., Xu, Y., Isenberg, J. S., Bachowski, S., Kolaja, K. L., Jiang, J., Stevenson, D. E., and Walborg, E. F., Jr. The role of oxidative stress in chemical carcinogenesis. Environ. Health Perspect., 106: 289-295, 1998.
4. Matés, J. M., Pérez-Gómez, C., and Núñez de Castro, I. Antioxidant enzymes and human diseases. Clin. Biochem., 32: 595-603, 1999.
5. 2 for platelet-derived growth factor signal transduction. Science (Wash. DC), 270: 296-299, 1995.
6. Finkel, T. Oxygen radicals and signaling. Curr. Opin. Cell Biol., 10: 248-253, 1998.
7. Kang, S. W., Chae, H. Z., Seo, M. S., Kim, K., Baines, I. C., and Rhee, S. G. Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor α. J. Biol. Chem., 273: 6297-6302, 1998.
8. Chae, H. Z., Robison, K., Poole, L. B., Church, G., Storz, G., and Rhee, S. G. Cloning and sequencing of thiol-specific antioxidant from mammalian brain, alkyl hydroperoxide reductase and thiol-specific antioxidant define a large family of antioxidant enzymes. Proc. Natl. Acad. Sci. USA, 91: 7017-7021, 1994.
9. Oberley, T. D., Verwiebe, E., Zhong, W., Kang, S. W., and Rhee, S. G. Localization of the thioredoxin system in normal rat kidney. Free Rad. Biol. Med., 30: 412-424, 2001.
10. Rabilloud, T., Heller, M., Gasnier, F., Luche, S., Rey, C., Aebersold, R., Benahmed, M., Louisot, P., and Lunardi, J. Proteomics analysis of cellular response to oxidative stress. Evidence for in vivo overoxidation of peroxiredoxins at their active site. J. Biol. Chem., 277: 19396-19401, 2002.
11. Kinnula, V. L., Lehtonen, S., Sormunen, R., Kaarteenaho-Wiik, R., Kang, S. W., Rhee, S. G., and Soini, Y. Overexpression of peroxiredoxins I, II, III, V and VI in malignant mesothelioma. J. Pathol., 196: 136-323, 2002.
12. Verdoucq, L., Vignols, F., Jacquot, J-P., Chartier, Y., and Meyer, Y. In vivo characterization of a Thioredoxin h target protein defines a new peroxiredoxin family. J. Biol. Chem., 274: 19714-19722, 1999.
13. Okado-Matsumoto, A., Matsumoto, A., Fujii, J., and Taniguchi, N. Peroxiredoxin IV is a secretable protein with heparin-binding properties under reduced conditions. J. Biochem., 127: 493-501, 2000.
14. Kang, S. W., Baines, I. C., and Rhee, S. G. Characterization of a mammalian peroxiredoxin that contains one conserved cysteine. J. Biol. Chem., 273: 6303-6311, 1998.
15. Fujii, T., Fujii, J., and Taniguchi, N. Augmented expression of peroxiredoxin VI in rat lung and kidney after birth implies an antioxidative role. Eur. J. Cancer, 268: 218-226, 2001.
16. Kim, H. S., Pak, J. H., Gonzales, L. W., Feinstein, S. I., and Fisher, A. B. Regulation of 1-cys peroxiredoxin expression in lung epithelial cells. Am. J. Respir. Cell Mol. Biol., 27: 227-233, 2002.
17. Declercq, J-P., Evrard, C., Clippe, A., Vander Stricht, D., Bernard, A., and Knoops, B. Crystal structure of human peroxiredoxin 5, a novel type of mammalian peroxiredoxin at 1.5 Å resolution. J. Mol. Biol., 311: 751-759, 2001.
18. Wang, M-X., Wei, A., Yuan, J., Clippe, A., Bernard, A., Knoops, B., and Murrell, A. C. Antioxidant enzyme peroxiredoxin 5 is upregulated in degenerative human tendon. Biochem. Biophys. Res. Commun., 284: 667-673, 2001.
19. Dhalla, N. S., Temsah, R. M., and Netticadan, T. Role of oxidative stress in cardiovascular diseases. J. Hypertens., 18: 655-673, 2000.
20. Ambrosone, C. B. Oxidants and antioxidants in breast cancer. Antioxid. Redox Signal., 2: 903-917, 2000.
21. Kim, S. H., Fountoulakis, M., Cairns, N., and Lubec, G. Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down syndrome. J. Neur. Transmission Suppl., 61: 223-235, 2001.
22. Haklar, G., Sayin-Ozveri, E., Yuksel, M., Aktan, A. O., and Yalcin, A. S. Different kinds of reactive oxygen and nitrogen species were detected in colon and breast tumors. Cancer Lett., 165: 219-224, 2001.
23. Willett, W. C., and MacMahon, B. Diet and cancer: an overview. N. Engl. J. Med., 310: 633-638, 1984.
24. Nelson, R. L. Dietary iron and colorectal cancer risk. Free Rad. Biol. Med., 12: 161-168, 1992.
25. Noh, D. Y., Ahn, S. J., Lee, R. A., Kim, S. W., Park, I. A., and Chae, H. Z. Overexpression of peroxiredoxin in human breast cancer. Anticancer Res., 21: 2085-2090, 2001.
26. Rosen, P. P. Rosen's Breast Pathology, Ed. 2. Philadelphia: Lippincott Williams & Wilkins, 2001.
27. Jin, D. Y., Chae, H. Z., Rhee, S. G., and Jeang, K. T. Regulatory role for a novel human thioredoxin peroxidase in NF-κB activation. J. Biol. Chem., 272: 30952-30961, 1997.
28. Seo, M. S., Kang, S. W., Kim, K., Baines, I. C., Lee, T. H., and Rhee, S. G. Identification of a new type of mammalian peroxiredoxin that forms an intramolecular disulfide as a reaction intermediate. J. Biol. Chem., 275: 20346-20354, 2000.
29. Yanagawa, T., Ishikawa, T., Ishii, T., Tabuchi, K., Iwasa, S., Bannai, S., Omura, K., Suzuki, H., and Yoshida, H. Peroxiredoxin I expression in human thyroid tumors. Cancer Lett., 154: 127-132, 1999.
30. Chang, J. W., Jeon, H. B., Jeung, H. L., Yoo, J. S., Chun, J. S., Kim, J. H., and Yoo, Y. J. Augmented expression of peroxiredoxin I in lung cancer. Biochem. Biophys. Res. Commun., 289: 507-512, 2001.
31. Yanagawa, T., Iwasa, S., Ishii, T., Tabuchi, K., Yusa, H., Onizawa, K., Omura, K., Harada, H., Suzuki, H., and Yoshida, H. Peroxiredoxin I expression in oral cancer: a potential new tumor marker. Cancer Lett., 156: 27-35, 2000.
32. Mitsumoto, A., Takanezava, Y., Okawa, K., Iwamatsu, A., and Nakagawa, Y. Variants of peroxiredoxin expression in response to hydroperoxide stress. Free Rad. Biol. Med., 30: 625-635, 2001.
33. Knoops, B., Clippe, A., Bogard, C., Arsalane, K., Wattiez, R., Hermans, C., Duconseille, E., Falmagne, P., and Bernard, A. Cloning and characterization of AOEB166, a novel mammalian antioxidant enzyme of the peroxiredoxin family. J. Biol. Chem., 274: 30451-30458, 1999.
34. Kim, H., Lee, T. H., Park, E. S., Suh, J. M., Park, S. J., Chung, H. K., Kwon, O. Y., Kim, Y. K., Ro, H. K., and Shong, M. Role of peroxiredoxins in regulating intracellular hydrogen peroxide and hydrogen peroxide-induced apoptosis in thyroid cells. J. Biol. Chem., 275: 18266-18270, 2000.
35. Zhang, P., Liu, B., Kang, S. W., Seo, M. S., Rhee, S. G., and Obeid, L. M. Thioredoxin peroxidase is a novel inhibitor of apoptosis with a mechanism distinct from that of Bcl-2. J. Biol. Chem., 272: 30615-30618, 1997.
36. Matés, J., M., and Sánchez-Jiménez, F. M. Role of reactive oxygen species in apoptosis: implications for cancer therapy. Int. J. Biochem. Cell Biol., 32: 157-170, 2000.